rs132630273
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000377.3(WAS):c.134C>G(p.Thr45Arg) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T45M) has been classified as Pathogenic.
Frequency
Consequence
NM_000377.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Wiskott-Aldrich syndromeInheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- X-linked severe congenital neutropeniaInheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- thrombocytopenia 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| WAS | NM_000377.3 | c.134C>G | p.Thr45Arg | missense_variant, splice_region_variant | Exon 2 of 12 | ENST00000376701.5 | NP_000368.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
WAS-related disorder Pathogenic:1
The WAS c.134C>G variant is predicted to result in the amino acid substitution p.Thr45Arg. To our knowledge, this variant has not been reported in the literature. However, different missense substitutions at this codon (e.g: p.Thr45Lys; p.Thr45Met) have been observed in individuals with Wiskott-Aldrich syndrome (Zhang et al. 2010. PubMed ID: 20546529; Kwan et al. 1995. PubMed ID: 7753869) suggesting that substitution of amino acid residue p.Thr45 is not tolerated. Additionally, an individual with this variant was found to have decreased WAS activity level (internal data at PreventionGenetics). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at